Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Discover index funds with standout Sharpe ratios over the last ten years and learn how risk-adjusted performance translates into better risk management.
27,590 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...
A quartz countertop tariff could raise renovation costs and ripple through the home-building supply chain, threatenin...
Retail XRP investors express anger as Ripple merges Swell with XRPL Apex and elevates RLUSD to the main stage. The ti...
A Northeast Ohio real estate team built on disciplined systems rises to No. 1 in Ohio among medium teams for 2025, wi...
Applied Digital signals a slower AI data-center buildout through 2027 amid labor constraints, with hyperscalers pushi...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...
Pump.fun’s PUMP token faces a major insider unlock totaling $127 million. If insiders hold, liquidity may hold; if th...
Two retirees withdraw the same amount from $2M portfolios, but after federal and state taxes they diverge sharply. Th...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...